Principal Investigator
Carl Landgren
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20251346
Clinical Trial Summary
AN OPEN-LABEL PHASE 1 STUDY TO EVALUATE PF-07994525 IN
PARTICIPANTS WITH ADVANCED MALIGNANCIES
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Myeloma
Contact Information
Phone Number
305-243-2647